UAE-based fertility technology company Ovasave has completed a $1.2 million pre-seed funding round to expand women’s healthcare services across the Gulf Cooperation Council region. The financing was led by PlusVC, Annex Investments, and New York-based 25 Madison, with participation from strategic angel investors and family offices in the UAE and Saudi Arabia.
The Hub71-supported startup plans to use the capital to launch operations in Saudi Arabia this summer as part of a three-year regional growth strategy. The funding will also support the development of an enhanced mobile application featuring artificial intelligence-driven treatment protocols and comprehensive menstrual cycle tracking capabilities.
Regional Healthcare Technology Growth
The investment reflects increasing interest in women’s health innovation across the Middle East and North Africa region. According to FemTech Analytics, the global FemTech market is expected to reach $3.8 billion by 2031, indicating substantial growth potential for companies operating in this sector.
Torkia Mahloul, Co-founder and CEO of Ovasave, stated: “There is a critical need for timely intervention in women’s health, particularly around fertility and hormonal health. This funding marks a crucial step in our mission to expand access to fertility and hormonal care across the region.”
Technology Platform Development
The startup’s forthcoming mobile application will integrate multiple healthcare monitoring features, including symptom tracking, care access, and personalised treatment recommendations powered by artificial intelligence. This approach aims to transform women’s healthcare from reactive to proactive management, potentially reducing costs while improving health outcomes.
Ovasave operates with registration from the Department of Health – Abu Dhabi and focuses specifically on fertility and hormonal health services. The company addresses healthcare needs in areas often considered sensitive topics with limited discussion in traditional medical settings.
Market Opportunity and Strategic Focus
The funding coincides with healthcare reforms and women’s rights initiatives across the UAE, creating favourable conditions for healthcare technology innovation. Co-founder Majd Abu Zant noted: “Abu Dhabi’s focus on innovation, healthcare, and entrepreneurship has created a competitive environment for founders and investors alike.”
Beyond direct consumer services, Ovasave plans to expand corporate partnerships throughout the GCC region. This B2B approach could provide additional revenue streams while extending the company’s reach through employer-sponsored healthcare programmes.
The startup’s growth strategy emphasises making women’s health support more accessible in markets where such services have traditionally been under-served. By combining technology solutions with regional expansion, Ovasave aims to address gaps in fertility and hormonal healthcare across multiple Gulf states.